Evidence map›Paper›PMID 36339343›Full record

ArticleFrontiers in cellular and infection microbiology2022

Engineered 5-HT producing gut probiotic improves gastrointestinal motility and behavior disorder.

Bei Li, Min Li, Yanan Luo, Rong Li, Wei Li, Zhi Liu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Genome-integrated engineering ofSynthetic and systems biotechnology · 2027
    Article
  3. Article
  4. Article
  5. The Role of Gut Microbiota in Liver Regeneration After Partial Hepatectomy: New Evidence From Animal and Human Studies.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Current and emerging approaches to manage chronic inflammatory gut disorders.Frontiers in cellular and infection microbiology · 2026
    Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Aqueous extract ofFrontiers in nutrition · 2025
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Bei LiDepartment of Biotechnology, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, China.
Min LiDepartment of Biotechnology, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, China.
Yanan LuoDepartment of Biotechnology, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, China.
Rong LiDepartment of Biotechnology, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, China.
Wei LiDepartment of Biotechnology, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, China.
Zhi LiuDepartment of Biotechnology, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, China.
Huazhong University of Science and Technology · CNMinistry of Education of the People's Republic of China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Slow transit constipation is an intractable constipation with unknown aetiology and uncertain pathogenesis. The gut microbiota maintains a symbiotic relationship with the host and has an impact on host metabolism. Previous studies have reported that some gut microbes have the ability to produce 5-hydroxytryptamine (5-HT), an important neurotransmitter. However, there are scarce data exploiting the effects of gut microbiota-derived 5-HT in constipation-related disease. We genetically engineered the probiotic

Indexed as

Mental DisordersProbioticsAnimalsConstipationEscherichia coliGastrointestinal MotilityMiceSerotoninSerotonin5-HTconstipationE. coli Nissle 1917engineered probioticgut microbiota

Identifiers

PMID36339343
PMCPMC9630942
OpenAlexW4306944975

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.